Insiders / Garg Pushkal / Activity
Activity — Garg Pushkal
59 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $747.1K | -2K -8.48% | 24,370 0.02% of shares | medium |
| Feb 13, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $695.2K | -2K -8.28% | 24,848 0.02% of shares | medium |
| Feb 27, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $384.2K | -1K -4.76% | 23,211 0.02% of shares | medium |
| Feb 27, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $313.2K | -942 -4.06% | 22,269 0.02% of shares | medium |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $248.4K | -767 -3.43% | 21,577 0.02% of shares | medium |
| Mar 5, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $239.4K | -740 -3.62% | 19,703 0.01% of shares | medium |
| Mar 5, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $210.8K | -654 -3.10% | 20,443 0.02% of shares | medium |
| Mar 3, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $205.1K | -640 -2.61% | 23,869 0.02% of shares | medium |
| Mar 5, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $165.5K | -510 -2.59% | 19,193 0.01% of shares | medium |
| Mar 5, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $163.0K | -500 -2.61% | 18,693 0.01% of shares | medium |
| Mar 3, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $148.9K | -463 -1.94% | 23,406 0.02% of shares | medium |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $137.6K | -421 -1.59% | 26,053 0.02% of shares | medium |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $115.7K | -353 -1.35% | 25,700 0.02% of shares | medium |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $113.1K | -350 -1.54% | 22,344 0.02% of shares | medium |
| Mar 3, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $112.4K | -355 -1.41% | 24,826 0.02% of shares | medium |
| Mar 3, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $101.1K | -317 -1.28% | 24,509 0.02% of shares | medium |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $93.0K | -289 -1.26% | 22,694 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $90.2K | -277 -1.04% | 26,474 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $88.4K | -272 -1.26% | 21,305 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $80.4K | -220 -0.96% | 22,803 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $72.6K | -199 -0.86% | 23,023 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $69.0K | -215 -0.93% | 22,983 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $67.7K | -208 -0.98% | 21,097 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $60.0K | -182 -0.71% | 25,411 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $55.8K | -155 -0.66% | 23,440 0.02% of shares | low |
| Feb 27, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $46.8K | -140 -0.63% | 22,129 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $44.1K | -123 -0.52% | 23,680 0.02% of shares | low |
| Feb 27, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $41.8K | -127 -0.47% | 26,629 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $35.4K | -98 -0.42% | 23,342 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $35.2K | -107 -0.42% | 25,593 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $34.3K | -96 -0.40% | 23,803 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $33.9K | -92 -0.41% | 22,620 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $33.8K | -106 -0.45% | 23,300 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $33.5K | -101 -0.40% | 25,223 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $32.6K | -102 -0.44% | 23,198 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $31.5K | -97 -0.36% | 26,751 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $30.5K | -85 -0.36% | 23,595 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $28.8K | -87 -0.34% | 25,324 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $26.5K | -73 -0.31% | 23,269 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $18.3K | -50 -0.22% | 22,753 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $17.1K | -47 -0.20% | 23,222 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $16.2K | -50 -0.19% | 26,848 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $15.1K | -41 -0.18% | 22,712 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $14.9K | -42 -0.18% | 23,940 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $14.8K | -40 -0.18% | 22,580 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $14.6K | -41 -0.17% | 23,899 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $14.0K | -42 -0.17% | 25,181 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $13.8K | -39 -0.16% | 23,982 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $7.1K | -19 -0.08% | 22,526 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $6.7K | -18 -0.08% | 22,562 0.02% of shares | low |